Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Coronary Heart Disease
Interventions
DRUG

Rosuvastatin or atorvastatin or simvastatin and clopidogrel

Trial Locations (18)

Unknown

Research Site, Danderyd

Research Site, Eksjö

Research Site, Falun

Research Site, Gothenburg

Research Site, Helsingborg

Research Site, Jönköping

Research Site, Karlskrona

Research Site, Karlstad

Research Site, Ljungby

Research Site, Lund

Research Site, Malmo

Research Site, Örebro

Research Site, Skövde

Research Site, Stockholm

Research Site, Sundsvall

Research Site, Uppsala

Research Site, Vaxjo

Research Site, Västerås

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY